Literature DB >> 9821112

Sarcoidosis of the cauda equina mimicking leptomeningeal malignancy.

L E Abrey1, M K Rosenblum, L M DeAngelis.   

Abstract

Isolated neurosarcoidosis can present with a wide range of central nervous system manifestations. We present two cases of cauda equina sarcoidosis misdiagnosed initially as leptomeningeal malignancy, and review the literature. This unusual manifestation of neurosarcoidosis is typified by an indolent, chronic process with limited response to corticosteroid therapy.

Entities:  

Mesh：

Year:  1998        PMID： 9821112     DOI： 10.1023/a:1005958205591

Source DB:  PubMed          Journal:  J Neurooncol        ISSN： 0167-594X            Impact factor:   4.130


  10 in total

Review 1.  [Cauda equina syndrome in sarcoidosis. Report of a case].

Authors:  S Chamaillard; F Dubas; I Penisson-Besnier
Journal:  Rev Rhum Mal Osteoartic       Date:  1990-12

2.  Sarcoid of the cauda equina. Case report.

Authors:  J N Campbell; P Black; P T Ostrow
Journal:  J Neurosurg       Date:  1977-07       Impact factor: 5.115

3.  [Peripheral neurologic manifestations of sarcoidosis].

Authors:  J P Emery; P P Lasserre; A Dryll
Journal:  Sem Hop       Date:  1972-11-14

4.  Neurological manifestations of sarcoidosis.

Authors:  W C Wiederholt; R G Siekert
Journal:  Neurology       Date:  1965-12       Impact factor: 9.910

5.  Sarcoidosis of the cauda equina: a report of three cases.

Authors:  J Zajicek
Journal:  J Neurol       Date:  1990-11       Impact factor: 4.849

Review 6.  Sarcoidosis of the spinal cord and medulla oblongata. A pathological and neuroradiological case report.

Authors:  M Graf; A Wakhloo; K Schmidtke; H Bloss; B Volk
Journal:  Clin Neuropathol       Date:  1994 Jan-Feb       Impact factor: 1.368

7.  Cerebrospinal fluid lysozyme and beta 2-microglobulin in neurosarcoidosis.

Authors:  V Oksanen; C Grönhagen-Riska; S Tikanoja; H Somer; F Fyhrquist
Journal:  J Neurol Sci       Date:  1986-03       Impact factor: 3.181

8.  MR of sarcoidosis in the head and spine: spectrum of manifestations and radiographic response to steroid therapy.

Authors:  F J Lexa; R I Grossman
Journal:  AJNR Am J Neuroradiol       Date:  1994-05       Impact factor: 3.825

9.  Therapeutic considerations in patients with refractory neurosarcoidosis.

Authors:  B N Agbogu; B J Stern; C Sewell; G Yang
Journal:  Arch Neurol       Date:  1995-09

10.  Angiotensin converting enzyme in cerebrospinal fluid: a new assay.

Authors:  V Oksanen; F Fyhrquist; H Somer; C Grönhagen-Riska
Journal:  Neurology       Date:  1985-08       Impact factor: 9.910
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.